| abstract |
The present invention relates to 2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperi Din-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-ennitrile free base (Compound (I)), Compound (I) ) and methods for preparing solid state forms of said salts. In addition, the present invention relates to a pharmaceutical composition comprising such a salt and a solid state form thereof, and a method for treating cancer, autoimmune and inflammatory diseases using Compound (I) or a pharmaceutically acceptable salt thereof. |